Prostate specific antigen levels after acute myocardial infarction

Acta Biochimica Polonica

Volumn 58, Issue 4, 2011, Pages 541-545

  Açikgöz, Şerefden ^a   Can, Murat ^a   Doǧan, Sait Mesut ^a   Mungan, Görkem ^a   Aydin, Mustafa ^a   Kelek, Serdar ^a   Sümbüloǧlu, Vildan ^a  

^a Zonguldak Karaelmas University   (Turkey)

Author keywords

Acute myocardial infarction; Free prostate specific antigen; Total prostate specific antigen

Indexed keywords

EID: 84860476921     PISSN: 0001527X     EISSN: 1734154X     Source Type: Journal    
DOI: 10.18388/abp.2011_2222     Document Type: Article

References (24)

1. Antman E, Bassand J-P, Klein W, Ohman M, Sendon JLL, Ryden L et al. (2000) The Joint European Society of Cardiology/American College of Cardiology Committee.
2. Myocardial Infarction Redefined - A Consensus Document of The Joint European Society of Cardiology/American College of Cardiology Committee for the Redefinition of Myocardial Infarction. (2000) J Am Coll Cardiol 36: 959-969.
3. Berent R, Auer J, Porodko M, Lamm G, Weber T, Wi{dotless}mmer E et al. (2006) Influence of cardiopulmonary resuscitation on levels of tumour markers. Eur J Cancer Care 15: 252-256.
4. Birkenmeier G, Struck F, Gebhardt R (1999) Clearance mechanism of prostate specific antigen and its complexes wi{dotless}th α2-macroglobulin and α1-antichymotrypsin. J Urol 162: 897-901.
5. Bjork T, Ljungberg B, Pi{dotless}i{dotless}ronen T, Abrahamsson PA, Pettersson K, Abraham T et al. (1998) Rapid exponential eliminati{dotless}on of free prostate speci{dotless}fi{dotless}c antigen contrasts the slow, capaci{dotless}ty limited elmination of PSA complexed to alpha1-antichymotrypsi{dotless}n from serum. Urology 51: 57-62.
6. Charlesworth MC, Young CY, Mi{dotless}ller VM, Ti{dotless}ndall DJ (1999) Kininogenase activity of prostate derived human glandular kallikrein (hk2) purified from seminal fluid. J Androl 20: 220-229.
7. Coker C, Sherwood RA, Crayford T, Saadeh F, Mulvin D, Brakenbury E et al. (1997) Ischemic damage to the prostate during cardiac surgery: A clinical model. The Prostate 32: 85-88.
8. Crook M, Preston K, Lancaster I (1997) Serum prostatic-antigen concentrations in acute myocardial infarction (Letter). Clin Chem 43: 1670.
9. Koller-Strametz J, Fritzer M, Gwechenberger M, Geppert A, Heinz G, Haumer M et al. (2000) Elevation of prostate-specific markers after cardiopulmonary resuscitation. Circulation 102: 290-293.
10. Marcondes S, Antunes E (2005) The plasma and tissue kininogenkallikrein-kinin system: role in the cardiovascular system. Curr Med Chem-Cardiovasc Hematol Agents 3: 33-34.
11. Messadi-Laribi E, Griol-Charhbili G, Gaies E, Vincent MP, Heudes D, Meneton P et al. (2008) Cardioprotection and kallikrein-kinin system in acute myocardial ischemia in mice. Clin Exp Pharmacol Physiol 35: 489-493.
12. Oesterling JE (1991) Prostate Specific Antigen: A critical assessment of the most useful tumor marker for adenocarcinoma of the prostate (Abstract). J Urol 145: 907-923.
13. Otto A, Bar J, Birkenmeier G (1998) Prostate-specific antigen forms complexes with human alpha 2 macroglobulin receptor/LDL receptor related protein. J Urol 159: 297-303.
14. Ozcan T, Bozlu M, Muslu N, Gozukara KH, Seyis S, Akcay B (2009) Elevation of the serum total and free prostate specific antigen levels after stent implantation in patients with coronary artery disease. Swiss Med Wkly 139: 672-675.
15. Parlaktas BS, Naseri E, Uluocak N, Elalmi{dotless}ş AO, Erdemir F, Etikan I (2006) Comparison of the effects of on-pump versus off-pump coronary artery bypass surgery on serum prostate-specific antigen levels. Int J Urol 13: 234-237.
16. Patane S, Marte F (2009a) Prostate specific antigen and acute myocardial infarction: A possible new intriguing scenario. Int J Cardiol 134: 147-149.
17. Patane S, Marte F (2009b) Prostate-specific antigen kallikrein: from prostate cancer to cardiovascular system. Eur Heart J 30: 1169-1170.
18. Patane S, Marte F (2010) Paroxysmal ventricular tachycardia and paroxysmal atrial fibrillation associated with subclinical hyperthyroidism, chronic renal failure and elevation of prostate-specific antigen during acute myocardial infarction (Letter). Int J Cardiol 138: 44-46.
19. Patane S, Marte F (2011) Prostate-specific antigen kallikrein and acute myocardial infarction: Where we are. Where are we going? Int J Cardiol 146: 20-22.
20. Patane S, Marte F, Bella GD, Ciccarello G (2009) Changing axis deviation, paroxysmal atrial fibrillation and elevation of prostate-specific antigen during acute myocardial infarction. (Letter). Int JCardiol 137: 37-40.
21. Patane S, Marte F, Sturiale M, Grassi R, Patane F (2010) Significant coronary artery disease associated with coronary artery aneurysm and elevation of prostate-specific antigen during acute myocardial infarction (Letter). Int J Cardiol 141: 39-42.
22. Rittenhouse HG, Finlay JA, Mikolajczyk SD, Partin AW (1998) Human kallikrein 2 (hk2) and prostate specific antigen (PSA): two closely related, but distinct, kallikreins in the prostate. (Abstract). Crit Rev Clin Lab Sci 35: 275-368.
23. Sharma JN (2006) Role of tissue kallikrein-kininogen-kinin pathways in the cardiovascular system. Arch Med Res 37: 299-306.
24. Sharma JN (2005) The Kallikrein-Kinin System: from mediator of inflammation to modulator of cardioprotection. Inflammopharmacology 12: 591-596.